Angiotech to participate in Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference



    VANCOUVER, Jan. 29 /CNW/ - Angiotech Pharmaceuticals, Inc. (NASDAQ:   ANPI,
TSX: ANP), a global specialty pharmaceutical and medical device company, is
scheduled to participate in the Merrill Lynch Global Pharmaceutical,
Biotechnology and Medical Device Conference, which is being held February 5-7
in New York, NY.
    Dr. William Hunter, Angiotech's President and Chief Executive Officer, is
scheduled to present on Tuesday, February 5, at the Grand Hyatt New York,
beginning at approximately 3:20 pm ET. A Question and Answer period will
immediately follow the presentation.
    A live audio-only webcast will be available to all interested parties on
the company's website, www.angiotech.com under the Investors section.

    About Angiotech

    Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and
medical device company with over 1,500 dedicated employees. Angiotech
discovers, develops and markets innovative treatment solutions for diseases or
complications associated with medical device implants, surgical interventions
and acute injury. To find out more about Angiotech (NASDAQ:   ANPI, TSX: ANP),
please visit our website at www.angiotech.com.





For further information:

For further information: Deirdre Neary, Manager, Investor Relations,
Angiotech Pharmaceuticals, Inc., (604) 222-7056, dneary@angio.com

Organization Profile

Angiotech Pharmaceuticals, Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890